The novel coronavirus disease 2019 (COVID-19) pandemic has had a particularly large influence on the specialty of otolaryngology–head and neck surgery. Molecular studies implicate nasal epithelial cells, specifically goblet and ciliated cells, as the entry site for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and a reservoir for dissemination within a given patient and from person to person. The development of acute loss of smell and taste was quickly recognized as one of the symptoms of COVID-19.1 Thus, otolaryngologists were placed in the front line of management and risk exposure for COVID-19. Now, reports of various acute and chronic neuropathies in patients with COVID-19 disease support the continued involvement by otolaryngologists.